Compawnion, a pet health and nutrition company, secured new funding led by East Ventures
Compawnion, an Indonesian pet food company, has secured a new funding led by East Ventures, the leading and pioneering sector-agnostic venture capital firm in Indonesia and Southeast Asia. The fund will be allocated to accelerate their distribution, research and development initiatives, broaden the company’s product portfolio, and effectively reach a larger demographic of pet owners who are looking for more health-conscious and sustainable choices for their beloved companions.
The future of Indonesian healthcare: Insights from Indonesia’s Minister of Health Budi Gunadi Sadikin and East Ventures’ Willson Cuaca
Indonesia's healthcare sector is on the brink of a significant transformation, and the catalysts were brought to light during a fireside chat at the Tech in Asia Conference 2023 in Jakarta. The discussion, titled 'The Future of Indonesian Healthcare,' featured a candid conversation between Mr. Budi Gunadi Sadikin, Indonesia's Minister of Health, and Willson Cuaca, Co-Founder and Managing Partner at East Ventures.
Harnessing the potential of an integrated ASEAN
Amidst global economic challenges, the ASEAN region stands out as a symbol of strength and adaptability. At the Tech In Asia Conference 2023, Roderick Purwana, Managing Partner at East Ventures shared his insight with Willis Wee, Founder of Tech in Asia, who also moderated the panel titled “Harnessing the potential of an integrated ASEAN.”
Inside Indonesia’s most financially literate provinces and what to learn from them
Across Indonesia’s vivid archipelago, a financial revolution is taking place. The nation’s financial landscape is transforming remarkably through the rise of the financial technology (fintech) industry. The latest edition of the East Ventures – Digital Competitiveness Index (EV-DCI) 2023 shows that the fintech development, leveraging on the enormous number of the productive-age population that earned an income, has been astounding. A fusion of financial innovation and education is reshaping the economic landscape and empowering communities like never before.
Moosa Genetics, an animal genomics and biotechnology startup, announced a new funding led by East Ventures
Moosa Genetics, an animal genomics and biotechnology startup based in Indonesia, announced that the company raised funding led by East Ventures, a pioneering and leading sector-agnostic venture capital firm focusing on Southeast Asia, with the participation from angel investors. This funding will be allocated to build laboratory, team, marketing, and wagyu partnership to fulfill the demand for its customers.
East Ventures and NalaGenetics’ commitment to supporting genomic sample analysis at the Biomedical and Genome Science Initiative (BGSi)
East Ventures, a pioneering and leading venture capital (VC) firm in Indonesia and Southeast Asia, has signed a Memorandum of Understanding (MoU) with NalaGenetics, a biotechnology company focused on personalized medicine, diet, and screening. This partnership is aimed to support genomic sample analysis in Indonesia's Biomedical and Genome Science Initiative (BGSi). The ceremonial signing of this MoU took place at the East Ventures booth during the Tech in Asia Conference 2023 and was attended by Budi Gunadi Sadikin, Minister of Health of the Republic of Indonesia.
East Ventures announced its first Healthcare fund of US$30 million
East Ventures, a pioneering and leading venture capital firm in Indonesia and Southeast Asia, today announced the firm’s first healthcare-focused fund with the amount of US$30 million, which is dedicated to supporting innovative healthcare solutions in Indonesia.
AMODA, an Indonesia-based property and construction technology startup, raised Seed funding co-led by East Ventures and Living Lab Ventures
AMODA, a property and construction technology startup in Indonesia, has secured seed funding co-led by East Ventures and Living Lab Ventures. This round of investment strengthens AMODA’s balance sheet, following the pre-seed funding in 2022. This funding will be mainly allocated to expanding its product, technology, and operation capabilities.